SCHEMBL8551020

SCHEMBL8551020

COC(=O)C(C)N1C(=O)CC1SCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ACE P12821 1/20 0.43
SLC1A2 P43004 1/20 0.40
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
CYP2C9 P11712 1/20 0.39
MAPT P10636 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8440266 0.87 ACE (0.46) ACESLC1A2ALDH1A1SMN1; SMN2
SCHEMBL8557349 0.85 L3MBTL1 (0.40) ACEALDH1A1CYP1A2POLBCYP2C9
SCHEMBL8552490 0.85 ALDH1A1 (0.42) ACEALDH1A1POLBCYP2C9MEN1
SCHEMBL27484036 0.85 ACE (0.40) ACEALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL8550015 0.83 ACE (0.38) ACEALDH1A1CYP1A2POLBCYP2C9
SCHEMBL8552407 0.83 SLC1A2 (0.58) ACESLC1A2ALDH1A1MEN1KMT2A
SCHEMBL8557133 0.82 ACE (0.37) ACEALDH1A1CYP1A2POLBCYP2C9
SCHEMBL8652713 0.81 EPHX1 (0.36) ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL27486422 0.79 MAPT (0.40) ACEALDH1A1MAPT
SCHEMBL8552273 0.78 ACE (0.37) ACEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0840725-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1998-05-13 EP disclosed
WO-1997002242-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-01-23 WO disclosed